EC approves Recordati's silodosin

The European Commission approved an MAA from Recordati S.p.A. (Milan:REC) for Silodyx/ Urorec silodosin to treat signs and symptoms of benign prostatic hyperplasia (BPH). Recordati plans to launch the...